MXPA03010498A - Proceso para la preparacion de imipenem. - Google Patents

Proceso para la preparacion de imipenem.

Info

Publication number
MXPA03010498A
MXPA03010498A MXPA03010498A MXPA03010498A MXPA03010498A MX PA03010498 A MXPA03010498 A MX PA03010498A MX PA03010498 A MXPA03010498 A MX PA03010498A MX PA03010498 A MXPA03010498 A MX PA03010498A MX PA03010498 A MXPA03010498 A MX PA03010498A
Authority
MX
Mexico
Prior art keywords
imipenem
preparation
improved
relates
present
Prior art date
Application number
MXPA03010498A
Other languages
English (en)
Inventor
Kumar Yatendra
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Publication of MXPA03010498A publication Critical patent/MXPA03010498A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/02Preparation
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

La presente invencion se relaciona a un proceso ventajoso industrialmente y efectivo en costo, mejorado, para la preparacion de imipenem.
MXPA03010498A 2001-05-18 2002-05-15 Proceso para la preparacion de imipenem. MXPA03010498A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN594DE2001 2001-05-18
PCT/IB2002/001670 WO2002094828A1 (en) 2001-05-18 2002-05-15 Process for the preparation of imipenem

Publications (1)

Publication Number Publication Date
MXPA03010498A true MXPA03010498A (es) 2004-05-27

Family

ID=11097061

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03010498A MXPA03010498A (es) 2001-05-18 2002-05-15 Proceso para la preparacion de imipenem.

Country Status (19)

Country Link
US (1) US7462712B2 (es)
EP (1) EP1395587B1 (es)
JP (1) JP2005508860A (es)
KR (1) KR20040002973A (es)
CN (1) CN1694885A (es)
AR (1) AR035978A1 (es)
AT (1) ATE437879T1 (es)
BR (1) BR0209842A (es)
CA (1) CA2447227A1 (es)
DE (1) DE60233130D1 (es)
DK (1) DK1395587T3 (es)
EA (1) EA007252B1 (es)
ES (1) ES2328117T3 (es)
MX (1) MXPA03010498A (es)
NO (1) NO20035136D0 (es)
PL (1) PL370705A1 (es)
PT (1) PT1395587E (es)
WO (1) WO2002094828A1 (es)
ZA (1) ZA200308958B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03010498A (es) * 2001-05-18 2004-05-27 Ranbaxy Lab Ltd Proceso para la preparacion de imipenem.
CN100383142C (zh) * 2003-12-09 2008-04-23 (株)中外制药 一种制备亚胺培南的方法
WO2006035300A2 (en) * 2004-09-30 2006-04-06 Ranbaxy Laboratories Limited A process for the preparation of meropenem
WO2010146449A1 (en) * 2009-06-18 2010-12-23 Orchid Chemicals And Pharmaceuticals Limited An improved process for the preparation of imipenam
CN101921274B (zh) * 2010-07-16 2012-09-26 深圳市海滨制药有限公司 一种制备亚胺培南的方法
CN101921275B (zh) * 2010-07-16 2012-09-26 深圳市海滨制药有限公司 一种制备亚胺培南的方法
CN101921273B (zh) * 2010-07-16 2012-09-26 深圳市海滨制药有限公司 一种制备亚胺培南的方法
JP6486835B2 (ja) 2013-01-18 2019-03-20 コデクシス, インコーポレイテッド カルバペネム合成に有用な人口生体触媒
CN110790765B (zh) * 2018-08-02 2022-08-05 江苏瑞科医药科技有限公司 一种亚胺培南的制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4194047A (en) * 1975-11-21 1980-03-18 Merck & Co., Inc. Substituted N-methylene derivatives of thienamycin
US4292436A (en) * 1980-06-25 1981-09-29 Merck & Co., Inc. Process for the preparation of N-protected N-formimidoyl 2-aminoethanethiol
US4745188A (en) * 1980-11-21 1988-05-17 Merck & Co., Inc. Process for preparing 3-substituted-6-substituted-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
US4374772A (en) * 1981-03-19 1983-02-22 Merck & Co., Inc. Process for the preparation of N-formimidoyl thienamycin and reagents therefor
US4640915A (en) * 1982-03-29 1987-02-03 Fujisawa Pharmaceutical Co., Ltd. 1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid derivatives
US4644061A (en) * 1982-09-28 1987-02-17 Bristol-Myers Company Carbapenem antibiotics
US4782051A (en) * 1985-06-10 1988-11-01 Merck & Co., Inc. 2-aza-substituted 1-carbadethiapen-2-em-3 carboxylic acids
US4894450A (en) * 1987-05-11 1990-01-16 Merck & Co., Inc. Process for 2-(aminoalkylthio) carbapenems
US5672701A (en) * 1990-01-16 1997-09-30 Bristol-Myers Squibb Company 4-substituted alkyl carbapenem antibiotics
WO1993021186A1 (en) * 1992-04-13 1993-10-28 Fujisawa Pharmaceutical Co., Ltd. Substituted 3-pyrrolidinylthio-carbapenems as antimicrobial agents
US5245069A (en) * 1992-10-27 1993-09-14 Merck & Co., Inc. Process for the preparation of bis(aryl)-phosphorohalidates
IN191798B (es) * 2000-11-03 2004-01-03 Ranbaxy Lab Ltd
OA12608A (en) * 2001-05-18 2006-06-08 Ranbaxy Lab Ltd Process for the isolation of crystalline imiponem.
MXPA03010498A (es) * 2001-05-18 2004-05-27 Ranbaxy Lab Ltd Proceso para la preparacion de imipenem.
CN100383142C (zh) * 2003-12-09 2008-04-23 (株)中外制药 一种制备亚胺培南的方法

Also Published As

Publication number Publication date
JP2005508860A (ja) 2005-04-07
EP1395587A1 (en) 2004-03-10
PL370705A1 (en) 2005-05-30
CA2447227A1 (en) 2002-11-28
NO20035136D0 (no) 2003-11-18
KR20040002973A (ko) 2004-01-07
EA200301224A1 (ru) 2004-12-30
ES2328117T3 (es) 2009-11-10
EA007252B1 (ru) 2006-08-25
CN1694885A (zh) 2005-11-09
US7462712B2 (en) 2008-12-09
EP1395587B1 (en) 2009-07-29
ATE437879T1 (de) 2009-08-15
ZA200308958B (en) 2004-07-19
EP1395587A4 (en) 2004-09-15
US20040220168A1 (en) 2004-11-04
AR035978A1 (es) 2004-07-28
DE60233130D1 (de) 2009-09-10
WO2002094828A1 (en) 2002-11-28
DK1395587T3 (da) 2009-10-12
BR0209842A (pt) 2005-01-04
PT1395587E (pt) 2009-09-03

Similar Documents

Publication Publication Date Title
TW200508201A (en) Novel process for the preparation of roflumilast
MXPA03011329A (es) Antiinfecciosos novedosos.
MXPA02004666A (es) Gelatinas recombinantes.
YU42803A (sh) Novi kristalni oblici atorvastatin hemi-kalcijuma i postupci za njihovo pripremanje kao i novi postupci za pripremanje drugih oblika
IL166710A0 (en) Process for the preparation of 4-ÄÄ4-ÄÄ-(2-cyanoethenyl)2,6-dimethylphenylÜaminoÜ-2-pyrimidinylÜaminoÜbenzonitrile
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
ECSP055584A (es) Proceso para la preparación de fibrinógeno
PL371127A1 (en) 6-aminomorphinane derivatives, method for the production and use thereof
MXPA04004604A (es) Proceso para la preparacion de imipenem cristalino.
GB0216002D0 (en) Process and composition
MXPA03010498A (es) Proceso para la preparacion de imipenem.
YU101402A (sh) Visoko prečišćeni preparati simvastatina
MXPA04000446A (es) 4-aminociclohexanoles sustituidos.
MXPA04004090A (es) Compuestos substituidos de 1h-quinolin-2-ona.
MXPA03008946A (es) Metodos para sintetizar compuestos que contienen fenol.
MXPA04000272A (es) Derivados de 4-aminociclohexanol sustituidos.
ZA200005110B (en) Process for preparing intermediates.
MXPA03010548A (es) Proceso para el aislamiento de imipenem cristalino.
PL346015A1 (en) Methoximinophenylacetic acid amides
AP2003002912A0 (en) Process for the preparation of amorphouse cilastatin sodium
WO2003007872A3 (en) Process for the preparation of citalopram hydrobromide
MXPA05003881A (es) Preparacion de compuestos triazospiro.
DE50006244D1 (en) Neue substituierte 3-phenoxy- und 3-phenylalkyloxy-2-phenyl-propylamine
MXPA03005400A (es) Metodo para preparacion de 11 (12)-pentadecen-15-olidos.
TW200407314A (en) Preparation of 4, 6-dichloro-5-fluoropyrimidine